Amgen Inc
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta, a pegylated protein to treat cancer patients; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Sensipar/Mimpara to treat secondary hyperparathyroidism; and EPOGEN to treat anemia caused by chronic kidney disease. It also markets other products in various markets, including Nplate, Vectibix, Repatha, Parsabiv, BLINCYTO, Aimovig, NEUPOGEN, Otezla, AMGEVITA, KANJINTI, EVENITY, IMLYGIC, MVASI, and Corlanor. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with Novartis; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; QIAGEN N.V.; and Adaptive Biotechnologies. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California. Show More...
-
Website http://www.amgen.com
-
Sector Healthcare
-
Industry Drug Manufacturers-General
-
Last Quote 248.60 EUR
-
Last Updated 29-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD 4.79 4.04 5.52 6.64 6.7 9.06 10.24 2.69 12.62 12.88 12.77 Dividends USD 0.56 1.44 1.88 2.44 3.16 3.0 4.6 5.28 5.8 5.95 Payout Ratio % * 6.9 24.3 28.0 36.2 35.6 37.9 31.2 133.0 43.5 46.6 Shares Mil 965.0 912.0 787.0 765.0 770.0 766.0 754.0 735.0 665.0 609.0 601.0 Book Value Per Share * EUR 19.53 22.86 19.87 20.94 27.4 33.95 39.43 37.38 19.94 16.52 14.41 Free Cash Flow Per Share * EUR 3.9 4.15 5.56 4.33 7.58 10.34 9.84 11.82 13.32 13.23 Return on Assets % 11.13 7.98 8.42 8.44 7.63 9.87 10.35 2.51 11.47 12.44 12.21 Financial Leverage (Average) 1.82 2.57 2.85 2.99 2.68 2.55 2.6 3.17 5.31 6.17 6.5 Return on Equity % 19.85 17.14 22.82 24.69 21.55 25.77 26.65 7.18 44.48 70.73 75.55 Return on Invested Capital % 13.21 9.84 11.24 11.35 10.33 12.69 13.3 3.53 16.87 19.31 19.47 Interest Coverage 9.8 7.8 5.76 6.15 6.21 8.29 8.27 8.36 7.86 8.09 7.85 Current Ratio 3.52 4.8 3.81 3.44 4.95 4.44 4.11 5.49 2.79 1.44 1.59 Quick Ratio 3.01 4.09 3.24 2.78 4.22 3.97 3.68 4.98 2.44 1.01 1.1 Debt/Equity 0.45 1.12 1.26 1.34 1.17 1.04 1.01 1.35 2.36 2.79 3.16